We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeiba Investme. Regulatory News (CBA)

Share Price Information for Ceiba Investme. (CBA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.00
Bid: 24.00
Ask: 32.00
Change: 0.00 (0.00%)
Spread: 8.00 (33.333%)
Open: 28.00
High: 28.00
Low: 28.00
Prev. Close: 28.00
CBA Live PriceLast checked at -
Ceiba Investments is an Investment Trust

To provide a regular level of income and substantial capital growth through investment in, and management of, a portfolio of Cuban real estate assets, with a focus on the tourism-related and commercial property sectors.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

3 Apr 2020 07:00

RNS Number : 6608I
Ceiba Investments Limited
03 April 2020
 

 

3 April 2020

 

CEIBA INVESTMENTS LIMITED

(the "Company")

 

(TICKER CBA, ISIN: GG00BFMDJH11)

Legal Entity Identifier: 213800XGY151JV5B1E88

 

 

 

COVID-19 Trading Update

 

 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

In the light of the rapidly evolving situation resulting from the spread of COVID-19 and its development into a global pandemic, CEIBA Investments Limited ("CEIBA" or the "Company"), the largest listed foreign company solely dedicated to investing in Cuba, with interests in the commercial and tourism real estate sectors of Cuba, today provides an update on current trading, operations and investments.

 

Cuba

 

Although Cuba is not escaping the impact of the COVID-19 pandemic (with some 170 plus confirmed cases and 4 deaths as at 1 April 2020), so far it is playing a remarkably positive role in the global health crisis. On 18 March 2020, Cuba allowed the British cruise ship, the MS Braemar, with at least five confirmed cases of coronavirus on board and 52 other passengers with symptoms, to dock at the Cuban port of Mariel and allow its 600, mainly British, passengers to board flights to the United Kingdom the same day. In addition, Cuba has sent hundreds of doctors to Italy, Brazil, Jamaica, Belize and other hard-hit countries, and the Cuban drug known as "Recombinant Human Interferon Alpha 2B" seems so far to be one of the more effective weapons against the COVID-19 virus. On 20 March 2020, Cuba announced a set of measures aimed at controlling the spread of COVID-19 within its national territory, which included border restrictions, and stopping the entry of tourists.

 

Current Trading, Operations and Investments

 

The Company can report that in the first two months of the current financial year there was no material COVID-19 impact on its operations, trading and investments. However, as of March 2020 hotel reservations for the year started to be affected by cancellations and decreasing flights to the Cuba, and the construction of the 400 room hotel in Trinidad, Cuba, experienced delays resulting from reduced construction imports from Europe.

 

Monte Barreto (as at 30 June 2019 held at US$71,736,000)

 

The operations of Inmobiliaria Monte Barreto S.A. ("Monte Barreto"), the owner and operator of the Miramar Trade Centre office complex in which the Company has a 49% interest, do not appear to be materially impacted. Only a limited number of tenants of Monte Barreto are airlines, travel agencies and other tourism related companies that have suffered an instant loss of income. Monte Barreto also has no debt financing and a cash balance in excess of US$10 million which would allow Monte Barreto to operate without income for an extended period of time if it were to become necessary. However, the general liquidity situation in Cuba may have a negative effect on the ability of Monte Barreto to distribute dividends to its shareholders, including CEIBA.

 

Hotel Investments in Havana and Varadero (as at 30 June 2019 held at US$75,107,499)

 

As a direct result of the measures announced by the Cuban government on 20 March 2020, Miramar S.A. ("Miramar"), the Cuban joint venture company in which CEIBA has a 32.5% interest, which owns and operates one hotel in Havana and three hotels in Varadero, Cuba's principal beach resort destination, is temporarily closing its hotels and substantially decreasing its workforce. Miramar has no debt financing and a healthy cash balance in excess of US$40 million which allows Miramar to operate without income for an extended period of time. However, the closing of the hotels will clearly have a negative effect on the results of Miramar and its ability to distribute dividends to its shareholders, including CEIBA.

 

Hotel Investment in Trinidad, Cuba (as at 30 June 2019 held at US$15,770,372)

 

In March 2020, the Italian-Cuban partnership that is constructing the 400-room beachfront hotel in Trinidad, Cuba, informed TosCuba S.A. ("TosCuba"), the Cuban joint venture company in which the Company has a 40% interest that the construction will be affected by the COVID-19 pandemic and will suffer delays. In parallel, CEIBA is presently in discussions with TosCuba to substantially lower the capital expenditure on the construction until there is greater certainty around the repatriation of dividends from Miramar and Monte Barreto that allow for the future financing and construction of the new hotel. This will inevitably extend the time-line and disbursement schedule of the construction and to set a new completion date of the turn-key construction contract. Further information will be provided when there is greater clarity on the development.

 

FINTUR Facility (as at 31 March 2020 the Company is owed €1,716,667)

 

As at 1 April 2020, the Company is owed €1,716,667 in a finance facility secured by offshore income from hotels in Cuba. Payment of the outstanding amount is scheduled to take place in three monthly installments ending on 30 June 2021, but this schedule will now likely be re-negotiated and the final payment date extended.

 

Liquidity

 

As at the date of this announcement, the balance sheet of the Company itself is strong and remains debt free and the operational Cuban joint venture companies in which it holds interests are well positioned to navigate the COVID-19 pandemic. The cash position of the Company at holding level as at 31 March 2020 was in excess of US$9 million.

However, the expected decrease in dividend income from the Cuban joint venture companies Miramar and Monte Barreto, in combination with the ongoing finance and investment requirements of TosCuba to construct the Trinidad hotel, have made it necessary to take several actions in order to safeguard the financial resources of the Company and ensure its future.

 

Board Actions Taken

 

The current main concern beyond employee welfare and safety is the impact of the COVID-19 pandemic on the Company. To mitigate the effects of the pandemic and continue to carry out its investment plans the Board has, amongst others, made the following decisions:

 

Ø to support the decision of Miramar to close its hotels in Havana and Varadero and substantially reduce its workforce;

Ø to support the decision of TosCuba to substantially lower capital expenditure on the construction and agree on a revised time-line and disbursement schedule at a time that there is greater certainty around the economic and financial viability of the hotel development;

Ø to discuss and agree with Casa Financiera FINTUR S.A. a new payment schedule for the €24 million and €12 million tranches (A and B) in which it originally had an aggregate €6 million participation with a present residual exposure of €1,716,667;

Ø to restrict discretionary spending and non-committed capital expenditure in Miramar and Monte Barreto;

Ø to carry out a detailed review of the costs and expenditures of the Company and its subsidiaries with a view to limit spending;

Ø to enter into discussions with third parties and shareholders in order to obtain a credit facility of up to €15 million.

 

 

Dividends

 

In addition to the decisions outlined above, the Board has decided that in light of the COVID-19 pandemic and the investment requirements of the Company, it is necessary to change the Company's dividend policy and not to declare a year-end dividend in respect of the 2019 financial year. The Board hopes to re-consider CEIBA's dividend policy for the year ending 31 December 2020, however this will depend on the length and severity of business disruption and the outlook for the remainder of the year. The Board will inform shareholders on their decision on whether to distribute a dividend in 2021 at the time of the announcement of the 2020 year-end results.

 

Outlook

 

Given the unprecedented levels of uncertainty at this time and the lack of clarity on the duration of business interruption, all previous guidance on the Company's future performance is being withdrawn. An update will be provided once there is greater certainty on the trading environment and the impact of COVID-19 on the Company and its operations and investments in Cuba. The Board remains confident in the long-term strong business fundamentals of the Company.

 

Financial Statements

 

The Company expects to issue its results for the year ended 31 December 2019 towards the end of April 2020 and not to seek temporary relief as offered by the Financial Conduct Authority on 26 March 2020 and to hold its Annual General Meeting as planned on 19 June 2020.

 

 

For further information, please contact:

 

Aberdeen Standard Fund Managers Limited

Sebastiaan Berger (Fund Manager)/Evan Bruce-Gardyne (Client Director, Investment Trusts)

 

 

+44 (0)78 2353 3062/+44 (0)77 2007 3216

N+1 Singer

James Maxwell / James Moat (Corporate Finance)

James Waterlow (Sales)

 

 

+44 (0)20 7496 3000

 

 

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTMZGGDLZNGGZM
12
Date   Source Headline
25th Mar 202411:03 amRNSDirectorate Change
17th Jan 20247:00 amRNSInvestment Update
27th Dec 20239:17 amRNSNet Asset Value(s)
18th Dec 20238:54 amRNSDirector/PDMR Shareholding
3rd Nov 202310:36 amRNSHolding(s) in Company
1st Nov 20239:05 amRNSDirector/PDMR Shareholding
27th Oct 202311:11 amRNSDirector/PDMR Shareholding
16th Oct 20238:37 amRNSAppointment of Non-Executive Director
12th Oct 20234:26 pmRNSDirector/PDMR Shareholding
5th Oct 202310:24 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSHalf-year Report
3rd Jul 20234:41 pmRNSUpdate re Internalisation of Management
28th Jun 20236:16 pmRNSResult of AGM
28th Jun 20236:05 pmRNSNet Asset Value(s)
27th Apr 20234:03 pmRNSAnnual Financial Report - Replacement
27th Apr 20237:00 amRNSInternalisation of Management
27th Apr 20237:00 amRNSAnnual Financial Report
7th Feb 20231:07 pmRNSHolding(s) in Company
14th Dec 20221:14 pmRNSCorrection: Half-year Report
1st Dec 20227:00 amRNSService Providers and Registered Office
30th Nov 202212:22 pmRNSNet Asset Value(s)
28th Sep 20227:00 amRNSHalf-year Report
1st Aug 20224:53 pmRNSAlternative Investment Fund Manager–Change of Name
4th Jul 202210:02 amRNSNet Asset Value(s)
16th Jun 20225:34 pmRNSResult of AGM
25th May 20223:38 pmRNSCorrection: Annual Financial Report
29th Apr 20229:45 amRNSAnnual Financial Report
23rd Feb 20227:00 amRNSNet Asset Value(s)
22nd Feb 20227:00 amRNSTrading Update
19th Jan 20224:48 pmRNSHolding(s) in Company
31st Dec 20211:27 pmRNSHolding(s) in Company
31st Dec 20211:26 pmRNSHolding(s) in Company
26th Nov 20214:34 pmRNSHolding(s) in Company
26th Nov 20213:24 pmRNSHolding(s) in Company
1st Oct 20217:00 amRNSAppointment of Non-Executive Director
28th Sep 20217:00 amRNSHalf-year Report
17th Jun 20212:47 pmRNSResult of AGM
28th Apr 20217:00 amRNSAnnual Financial Report
14th Apr 20217:00 amRNSListing of Convertible Bonds
31st Mar 202112:16 pmRNSTrading Statement
15th Jan 20217:00 amRNSNet Asset Value(s)
16th Dec 20207:00 amRNSTrading Statement
3rd Dec 20204:30 pmRNSResult of Extraordinary Meeting
13th Nov 20207:00 amRNSNotice of EGM
23rd Oct 20207:00 amRNSTrading Statement
9th Oct 20204:59 pmRNSHalf-year Report
29th Sep 20207:00 amRNSHalf-year Report
19th Jun 20204:00 pmRNSResult of AGM
8th Jun 20207:00 amRNSTrading Statement
20th May 20205:40 pmRNSNet Asset Value(s)
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.